Moneycontrol PRO
Loans
HomeNewsMarksanspharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Trade Spotlight: How should you trade Kotak Mahindra Bank, Aadhar Housing, Kansai Nerolac, Kfin Tech, Mankind Pharma, Zydus Life, and others on September 19?

    The market may see some consolidation, but overall, the mood remains bullish. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade Wipro, NLC India, Bharat Electronics, Mazagon Dock, VIP Industries, Hindustan Aeronautics, and others on September 11?

    Trade Spotlight: How should you trade Wipro, NLC India, Bharat Electronics, Mazagon Dock, VIP Industries, Hindustan Aeronautics, and others on September 11?

    The trend is likely to be upward despite consolidation (if any), as frontline indices now trade above all key moving averages. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade Bajaj Finance, Mankind Pharma, ITC, Deepak Nitrite, IndusInd Bank, SBI Card, and others on February 4?

    Trade Spotlight: How should you trade Bajaj Finance, Mankind Pharma, ITC, Deepak Nitrite, IndusInd Bank, SBI Card, and others on February 4?

    As long as the market defends the midline of Bollinger Bands, the trend may remain in favour of bulls despite Monday's profit booking. Below are some trading ideas for the near term.

  • Trade Spotlight: How should you trade Lupin, Muthoot Finance, Trent, HEG, Tube Investments, and others on Friday?

    Trade Spotlight: How should you trade Lupin, Muthoot Finance, Trent, HEG, Tube Investments, and others on Friday?

    After the significant weakness over the last four days, the market may see consolidative and rangebound trading with a slightly negative bias. Below are some trading ideas for the near term:

  • Trade Spotlight: How should you trade Siemens, Mankind Pharma, Kotak Bank, DLF, Indegene and others on Tuesday?

    Trade Spotlight: How should you trade Siemens, Mankind Pharma, Kotak Bank, DLF, Indegene and others on Tuesday?

    The Nifty 50 is likely to continue its upward journey, with the possibility of some consolidation. Below are some trading ideas for the near term.

  • Hot Stocks | Ircon International, Mankind Pharma, Bikaji Foods may return in double digits

    Hot Stocks | Ircon International, Mankind Pharma, Bikaji Foods may return in double digits

    For Nifty50, 19,330 is an immediate support level, while 19,220 is a key support level. The overall texture is still 'buy on dip'.

  • Buy Marksans Pharma, says Rajat Bose

    Buy Marksans Pharma, says Rajat Bose

    Rajat Bose of rajatkbose.com suggests buying Marksans Pharma.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347